Alnylam Pharmaceuticals | صافي الدخل



Net Income تغيير تاريخ
Acadia Pharmaceuticals USD 18.99M 124.76M 2025-03
Agios Pharmaceuticals USD -89289000 7.23M 2025-03
Alnylam Pharmaceuticals USD -57479000 26.28M 2025-03
Amgen USD 1.73B 1.1B 2025-03
Arrowhead Research USD 370.44M 543.53M 2025-03
BioMarin Pharmaceutical USD 185.69M 60.74M 2025-03
Incyte USD 158.2M 43.01M 2025-03
Ionis Pharmaceuticals USD -146938000 42.59M 2025-03
Moderna USD -971000000 149M 2025-03
Neurocrine Biosciences USD 103.1M 26.7M 2024-12
Novartis USD 2.82B 371M 2024-12
PTC Therapeutics USD -65886000 40.77M 2024-12
Regeneron Pharmaceuticals USD 808.7M 109M 2025-03
Sanofi EUR 499M 2.32B 2024-12
Sarepta Therapeutics USD -447508000 606.56M 2025-03
Takeda JPY -103155000000 126.94B 2025-03
Tectonic Therapeutic USD -12373000 5.34M 2024-12
Ultragenyx Pharmaceutical USD -151080000 17.7M 2025-03
Vertex Pharmaceuticals USD 913M 132.4M 2024-12
Xencor USD -53479000 8.34M 2024-12



Alnylam Pharmaceuticals صافي الدخل - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - May 2025.